Search

everythinglearnresearchcommunity

for

Search:↓

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The new skin model can predict how chemicals might cause skin allergies.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Fetal skin has unique immune cells different from adult skin.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Clonally expanded CD8+ T cells cause alopecia areata.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.

CD44 variant changes start alopecia areata, but don't maintain it.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.